FABRAZYME

Google image searchProduct monograph

Active ingredient

agalsidase beta, 35 MG/VIAL

DIN: 02248966

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 08-APR-2024

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB04 — AGALSIDASE BETA (ATC/DDD)

Reference brand drug: Fabrazyme

External Links for Fabrazyme

Search on Google

• Fabrazyme side effects
• Fabrazyme dosage
• agalsidase beta side effects
• agalsidase beta dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find fabrazyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.